According to Research, the Antitumor activity and biological effects resulting from the administration of Metronomic low-dose oral cyclophosphamide and methotrexate indicated that it was efficacious and low in toxicity.
<h3>What is Metronomic low-dose oral cyclophosphamide and methotrexate?</h3>
This is a drug which as at 2005 was being used for clinical trials on patients with tumor or cancerous growth.
The treatment also showed that there was a drop in Vascular Endothelial Growth Factor (VEGF).
It is to be noted that there was no noticeable improvements with the addition of thalidomide.
